TIAA Trust National Association Buys 191 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

TIAA Trust National Association raised its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 15.1% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 1,457 shares of the biotechnology company’s stock after purchasing an additional 191 shares during the quarter. TIAA Trust National Association’s holdings in Axon Enterprise were worth $866,000 as of its most recent filing with the SEC.

Other large investors have also made changes to their positions in the company. DRW Securities LLC bought a new position in Axon Enterprise during the third quarter valued at about $291,000. The Manufacturers Life Insurance Company grew its holdings in shares of Axon Enterprise by 0.6% during the 3rd quarter. The Manufacturers Life Insurance Company now owns 43,643 shares of the biotechnology company’s stock worth $17,440,000 after purchasing an additional 276 shares in the last quarter. Dai ichi Life Insurance Company Ltd increased its position in shares of Axon Enterprise by 63.6% during the third quarter. Dai ichi Life Insurance Company Ltd now owns 3,646 shares of the biotechnology company’s stock valued at $1,457,000 after purchasing an additional 1,418 shares during the period. D.A. Davidson & CO. raised its stake in shares of Axon Enterprise by 0.3% in the third quarter. D.A. Davidson & CO. now owns 12,622 shares of the biotechnology company’s stock valued at $5,044,000 after purchasing an additional 44 shares in the last quarter. Finally, Quantbot Technologies LP bought a new position in Axon Enterprise in the third quarter worth $84,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Axon Enterprise Trading Down 1.5 %

AXON stock opened at $550.65 on Friday. The business has a fifty day moving average price of $590.80 and a 200 day moving average price of $546.79. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. Axon Enterprise, Inc. has a fifty-two week low of $273.52 and a fifty-two week high of $715.99. The stock has a market capitalization of $42.19 billion, a price-to-earnings ratio of 142.29, a P/E/G ratio of 5.17 and a beta of 1.12.

Insider Transactions at Axon Enterprise

In related news, Director Jeri Williams sold 307 shares of the business’s stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $552.72, for a total value of $169,685.04. Following the completion of the transaction, the director now owns 1,627 shares in the company, valued at $899,275.44. The trade was a 15.87 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the transaction, the director now owns 6,929 shares in the company, valued at $4,185,601.03. The trade was a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 6.10% of the company’s stock.

Analyst Ratings Changes

Several brokerages have issued reports on AXON. JMP Securities reissued an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their target price for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Needham & Company LLC reissued a “buy” rating and issued a $600.00 price target on shares of Axon Enterprise in a research report on Wednesday, February 26th. Barclays reaffirmed a “hold” rating on shares of Axon Enterprise in a report on Monday, March 10th. Finally, The Goldman Sachs Group increased their target price on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a report on Monday, January 27th. One research analyst has rated the stock with a sell rating, two have given a hold rating and eleven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Axon Enterprise has a consensus rating of “Moderate Buy” and an average target price of $604.67.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.